期刊文献+

帕金森病患者认知功能障碍早期诊断的探讨 被引量:8

Early Diagnosis of Cognitive Impairment in Parkinson's Disease
原文传递
导出
摘要 目的分析帕金森病(PD)患者认知功能障碍的临床特点,探讨其发生机制,为帕金森病认知障碍早期诊断和干预提供策略。方法比较分析北京世纪坛医院收治的50例帕金森病患者与50例非帕金森病患者的临床资料,包括脑部CT和MRI扫描数据、MSSE评分、UPDRS评分及韦氏成人智力量表测验结果,筛查早期诊断帕金森病认知功能障碍的主要识别参数,如影像学参数和认知功能评分。结果帕金森病组MSSE评分、各分测量表评分、言语智商(VIQ)、操作智商(PIQ)、记忆商(MQ)、UPDRS评分均明显低于正常对照组,差异具有显著性(P<0.01);两组头颅CT或MRI的额叶脑沟宽度、顶叶脑沟宽度、侧脑室体部宽度指数等参数,差异具有统计学意义(P<0.01)。结论部分帕金森病患者存在认知功能障碍。帕金森病症状越重者,认知功能障碍也更明显,且记忆损害比智力受损严重。PD认知障碍的主要病理形态学改变可能为额叶脑沟宽度、顶叶脑沟宽度、侧脑室体部宽度指数的改变。 Objective To analyze the clinical features of cognitive impairment in patients with Parkinson' s disease (PD), and explore its mechanism for early diagnosis of Parkinson' s cognitive impairment. Methods The clinical data of 50 patients with PD and 50 non-PD patients were compared, which included data of brain CT and MRI scan results, MSSE score, UPDRS score, and the Wechsler Adult Intelligence Scale subtests results, main identification parameters screening for early diagnosis of cognitive dysfunction in PD, such as imaging parameters and cognitive function scores. Results The scores of MSSE, VIQ, PIQ, MQ and UPDRS of PD group were significantly lower than those in the control group (P〈0.01). The mean widths of the cerebral sulci of the frontal lobe, parietal lobe, and lateral body measured by head CT or MRI were lower in PD group than in the non-PD group (P〈0.01). Conclusion PD patients have some cognitive impairment, the more severe the symptoms of Parkinson' s disease, the more obvious the cognitive dysfunction; and the intellectual impairment is severe than memory impairment is. The major pathological changes of PD cognitive impairment may be appeared as the width changes of cerebral sulci of the frontal lobe, parietal lobe and lateral body.
出处 《中国慢性病预防与控制》 CAS 北大核心 2011年第6期591-593,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 帕金森病 认知功能障碍 早期诊断 Parkinson' s disease Cognitive impairment Early diagnosis
  • 相关文献

参考文献15

  • 1吉中国,范璞.帕金森综合征[J].山东医药,2009,49(31):104-105. 被引量:9
  • 2赵大龙,王珂.α-synuclein与帕金森病[J].中国医药生物技术,2010,5(4):300-304. 被引量:3
  • 3牛小莉,孙万彬,李双成.帕金森病发病因素的初步探讨[J].现代中西医结合杂志,2009,18(3):342-343. 被引量:4
  • 4Langston JW,Windner H,Goetz CG, et al. Core assessment program for intracerebra 1 transplatations (CAPIT) [J]. Mov Disord, 1992,7 : 2-13.
  • 5汪向东 王希林 马弘 等.心理卫生评定量表手册[M] 增订版[M].北京:中国心理卫生杂志社,1999.35-45.
  • 6陈海波 王新德.统一帕金森病评定量表[J].中华老年医学杂志,1999,18(1):61-62.
  • 7龚耀先.韦氏成人智力量表中国修订本[M].长沙:湖南地图出版社,1993.21.
  • 8吴恩惠.头颅CT诊断学[M].2版.北京:人民卫生出版社,1996:24-35.
  • 9Korczyn AD.Dementia in Parkinson' s disease [J].J Neurol, 2001,248: 1-4.
  • 10Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson's disease: a ,community -based,prospective study[J]. Neurology, 2001,56 : 730-736.

二级参考文献17

  • 1Fan GH Zhou HY Yang H Chert SD.Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells.[J].中国生物学文摘,2006,20(9):28-28. 被引量:6
  • 2Wakabayashi K,Tanji K,Mori F,et al. The Lewy body in Parkinson's disease:molecules implicated in the formation and degradation of alpha-synuclein aggregates [ J ]. Neuropathology, 2007,27 ( 5 ) : 494 - 506
  • 3Collier T J, Lipton J, Daley BF, et al. Aging-Related Changes in the Nigrostriatal Dopamine System and the Response to MPTP in Non-human Primates: Diminished Compensatory Mechanisms as a Prelude to Parkinsonism[ J ]. Neurobiol Dis, 2007,26 ( 1 ) : 56 - 65
  • 4Clarke G, Lumsden CJ, Mclnnes RR. Inherited neurodegenerative diseases: the one-hit model of neurodegeneration [ J ]. Hum Mol Genet,2001,10(20) :2269 - 2275
  • 5Di Monte DA,Lavasani M, Manning-Bog AB. Environmental factors in Parkinson' s disease [ J ]. Neurotoxieology, 2002,23 ( 4/5 ) : 487-502
  • 6Lee FJ,Liu F,Pristupa ZB,et al. Direct binding and functional coupling of alpha-synuelein to the dopamine transporters accelerate dopamine-indueed apoptosis[ J ]. FASEB J ,2001,15(6) :916- 926
  • 7Prediger RD,Batista LC, Medeiros R,et al. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Experimental[J]. Neurology,2006, 202(2) :391 - 403
  • 8Rojo AI, Montero C, Salazar M, et al. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice [J]. Eur J Neurosci,2006,24(7) :1874- 1884
  • 9Bradbury A J, Costall B, Domeney AM, et al. 1 - methyl - 4 - phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway [J]. Nature,1986,319(6048):56-57
  • 10Manning-Bo AB, Caudle WM, Perez XA, et al. Increased vulnerability of nigrostriatal terminals in DJ - 1 - deficient mice is mediated by the dopamine transporter[J]. Neurobiol Dis,2007,27(2) :141 -50

共引文献326

同被引文献58

  • 1胡丹,梁直厚,王涛,孙圣刚.脑源性神经营养因子基因多态性与散发性帕金森病的相关性研究[J].脑与神经疾病杂志,2006,14(4):268-270. 被引量:3
  • 2马桂贤,王丽娟.血管性认知障碍的分子机制和遗传学[J].国际脑血管病杂志,2006,14(11):819-822. 被引量:35
  • 3张留莎,张萍,王传升.帕金森病患者生活质量指数对照研究[J].临床心身疾病杂志,2007,13(4):327-328. 被引量:2
  • 4Hughes TA,Ross HF,Musa S,et al.A 10-year study of the incidence and factors predicting in Parkinson′ s disease[J].Neurology,2000,54(8):1596-1602.
  • 5Emre MD.Emetia associated with Parkinson′s disease[J].Lancet Neurol,2003,2(2):229-237.
  • 6De Lau LM,Koudstaal PJ,Hofman A,et al.Serum uric acid levels and the risk of Parkinson′s disease[J].Ann Neurol,2005,58(5):797-800.
  • 7Weisskopf MG,O′Reilly E,Chen H,et al.Plasma urate and risk of Parkinson′s disease[J].Am J Epidemiol,2007,166(5):561-567.
  • 8Aarsland D,Zaccai J,Brayne A.A systematic review of prevalence studies of dementia in Parkinson′s disease[J].Mov Disord,2005,20(10):1255-1263.
  • 9Lieberman A.Are dementia and depression in Parkinson′s disease related[J].Neurol Sci,2006,248(1-2):138-142.
  • 10Williams-Gray CH,Foltynie T,Brayne CE,et al.Evolution of cognitive dysfunction in an incident Parkinson′s disease cohort[J].Brain,2007,130(7):1787-1798.

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部